Skip to main content
. 2013 Nov 13;22(6):809–813. doi: 10.1038/ejhg.2013.242

Table 1. Baseline characteristics.

  CAD+
CAD
 
  n=482 n=1212 P-value
Age first visit lipid clinic (years) 50.5 (11.1) 42.2 (12.3) <0.0001
Age last visit lipid clinic (years) 57.1 (11.2) 46.6 (12.5) <0.0001
Male gender 301 (62) 516 (42) <0.0001
Diabetes mellitus 54 (11) 45 (4) <0.0001
Hypertension 79 (16) 77 (6) <0.0001
History of smoking 365 (75) 766 (63) <0.0001
Body mass index, kg/m2 25.7±3.2 24.9±3.6 <0.0001
Family history CVD 204 (42) 607 (50) 0.005
       
Treatment-naive lipids levels:
 Total cholesterol, mmol/l 9.6 (2.1) 9.4 (1.9) 0.146
 LDL-cholesterol, mmol/l 7.0 (1.9) 7.2 (1.8) 0.152
 HDL-cholesterol, mmol/l 1.1 (0.3) 1.2 (0.4) <0.0001
 Triglyceridesa, mmol/l 1.8 (1.3–2.5) 1.5 (1.0–2.0) <0.0001
 LDL-receptor mutation provenb 207 (43) 655 (54) 0.017
 Age of CAD onset, years 49.1±10.7 Na Na
 Age of start statin use 48.8±11.5 40.9±12.6 <0.0001

Abbreviations: CAD, coronary artery disease; CVD, cardiovascular disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

Values are given as number (percentage) or mean±SD unless indicated otherwise.

a

Mean±interquartile range.

b

Mutations of the LDL receptor that have been examined according to Umans-Eckenhausen MA et al.13